Nevertheless, our study paves the way to develop MANF-based therapies for human disorders, including β cell death in type 1 and type 2 diabetes, neurodegenerative diseases, and Wolfram syndrome characterized by juvenile onset-diabetes, optic nerve atrophy, and neurodegeneration. The gene discussed is MANF; the disease is Wolfram syndrome.